Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phathom Pharmaceuticals

2.76
-0.6000-17.86%
Post-market: 2.820.0600+2.17%19:58 EDT
Volume:4.70M
Turnover:13.58M
Market Cap:188.72M
PE:-0.52
High:3.40
Open:3.38
Low:2.71
Close:3.36
Loading ...

Phathom Pharmaceuticals Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
6 hours ago

Phathom Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Yesterday

Phathom Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $20 From $28

THOMSON REUTERS
·
Yesterday

Phathom Pharmaceuticals Reports Q1 2025 Financial Results

TIPRANKS
·
Yesterday

Phathom Pharmaceuticals Eyes Profitability Amid Growth

TIPRANKS
·
Yesterday

Phathom Pharmaceuticals Inc. Announces New Compensation Plan with Inducement Awards for Senior VP Jonathan Bentley

Reuters
·
Yesterday

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Yesterday

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Yesterday

BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, Wayfair, Moderna

Reuters
·
Yesterday

Positive Outlook for Phathom Pharmaceuticals Amid Cost-Cutting and Regulatory Catalysts

TIPRANKS
·
Yesterday

Phathom Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
01 May

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue Estimates

Zacks
·
01 May

UPDATE: Phathom Pharmaceuticals Q1 Adj. EPS $(1.07) Beats $(1.15) Estimate,

Benzinga
·
01 May

Phathom Pharmaceuticals reports Q1 EPS ($1.07), consensus ($1.07)

TIPRANKS
·
01 May

BRIEF-Phathom Pharmaceuticals Q1 Net Income USD -94.316 Million

Reuters
·
01 May

Phathom Pharmaceuticals Inc - to Reduce Headcount by Approximately 6%

THOMSON REUTERS
·
01 May

Phathom Pharmaceuticals Inc - Implements Cost Reductions and Leadership Changes for Growth

THOMSON REUTERS
·
01 May

Phathom Pharmaceuticals Inc - Expects $60-$70 Million Reduction in 2025 Operating Expenses

THOMSON REUTERS
·
01 May

Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire
·
01 May

Phathom Pharmaceuticals Inc expected to post a loss of $1.15 a share - Earnings Preview

Reuters
·
29 Apr